Sex-specific cytotoxicity of ostarine in cardiomyocytes

cris.virtual.author-orcid0000-0002-0081-7585
cris.virtual.author-orcid0000-0002-7182-6905
cris.virtual.author-orcid0000-0001-5209-2232
cris.virtual.author-orcid0000-0001-9792-1145
cris.virtual.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.author-orcid0000-0003-0715-0223
cris.virtualsource.author-orcidfa9a05b6-07fa-47e8-ae3d-8929da6881f3
cris.virtualsource.author-orcid325904ea-6775-4d8a-b846-0104d9ec20ca
cris.virtualsource.author-orcid59d1337d-8f96-43d3-bd28-674f4db5b81d
cris.virtualsource.author-orcid1815dbc7-82a3-4ce5-8dc9-bbe17826792b
cris.virtualsource.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtualsource.author-orcid0c22ceb5-e5c6-4f5d-a0fd-8ec91a16efa9
dc.abstract.enOstarine is the most popular compound in the selective androgen receptor modulator group (SARMs). Ostarine is used as a physical performance-enhancing agent. The abuse of this agent in higher doses may lead to severe side effects. Here, we evaluate the effects of ostarine on the heart. We utilized a cardiomyocyte H9C2 cell line, isolated primary female and male cardiac fibroblast cells, as well as hearts obtained from rats. Ostarine increased the accumulation of two fibrosis protein markers, αSMA and fibronectin (p < 00.1) in male, but not in female fibroblast cells. Ostarine increased the expression of the cardiomyopathy marker βMhc in the H9C2 cell line (p < 0.05) and in the heart in rats (p < 0.01). The unfavorable changes were observed at high ostarine doses. Moreover, a decrease in viability and an increase in cytotoxicity marker LDH were observed already at lowest dose (1 nmoL/l). Taken together, our results suggest that ostarine is cardiotoxic which may be more relevant in males than in females.
dc.affiliationWydział Medycyny Weterynaryjnej i Nauk o Zwierzętach
dc.affiliation.instituteKatedra Fizjologii, Biochemii i Biostruktury Zwierząt
dc.contributor.authorLeciejewska, Natalia
dc.contributor.authorPruszyńska-Oszmałek, Ewa
dc.contributor.authorNogowski, Leszek
dc.contributor.authorSassek, Maciej
dc.contributor.authorStrowski, Mathias Z.
dc.contributor.authorKołodziejski, Paweł
dc.date.access2025-07-30
dc.date.accessioned2025-10-28T12:03:33Z
dc.date.available2025-10-28T12:03:33Z
dc.date.copyright2023-08-03
dc.date.issued2023
dc.description.accesstimeat_publication
dc.description.bibliographyil., bibliogr.
dc.description.financepublication_nocost
dc.description.financecost0,00
dc.description.if3,8
dc.description.number1 November 2023
dc.description.points100
dc.description.versionfinal_published
dc.description.volume577
dc.identifier.doi10.1016/j.mce.2023.112037
dc.identifier.eissn1872-8057
dc.identifier.issn0303-7207
dc.identifier.urihttps://sciencerep.up.poznan.pl/handle/item/5541
dc.identifier.weblinkhttps://www.sciencedirect.com/science/article/pii/S0303720723001880
dc.languageen
dc.relation.ispartofMolecular and Cellular Endocrinology
dc.relation.pagesart. 112037
dc.rightsCC-BY
dc.sciencecloudnosend
dc.share.typeOTHER
dc.titleSex-specific cytotoxicity of ostarine in cardiomyocytes
dc.typeJournalArticle
dspace.entity.typePublication
oaire.citation.volume577